Maharashtra to get over 4 lakh Remdesivir vials by month-end from Centre

Maharashtra Chief Minister Uddhav Thackeray on Saturday stated the state will receive 4.35 lakh vials of Remdesivir from the Centre
Remdesivir is an antiviral medication developed by Gilead Sciences to battle COVID-19 virus
Remdesivir is an antiviral medication developed by Gilead Sciences to battle COVID-19 virusImage source: Flickr

Mumbai: Maharashtra Chief Minister Uddhav Thackeray on Saturday stated the state will receive 4.35 lakh vials of Remdesivir which is in huge demand for the period between April 21 to April 30 from the central government. He also thanked Prime Minister Narendra Modi for accepting the Maharashtra’s demand to ramp up the supply of Remdesivir which is considered as life-saver drug during the COVID-19 crisis.

He had mentioned the need for more doses of Remdesivir, used for the treatment of COVID-19, in the meeting chaired by Prime Minister Narendra Modi with chief ministers of the state. CM Thackeray also had written to the PM separately on the issue. "The present supply was 2.69 lakh vials which has been increased to 4.35 lakh vials," he said.

The state government had received a letter from the Union health ministry that this supply of Remdesivir will be for the period between April 21 to April 30, he informed. Out of 16 lakh vials to be provided to the states during this period, Maharashtra will get 4.35 lakh, Thackeray stated.

SERUM HAS ASSURED 'MAXIMUM SUPPORT': CMO MAHARASHTRA

Serum Institute of India (SII) has assured Maharashtra CM Uddhav Thackeray of 'maximum support' in vaccinating the people around the state at the earliest, Chief Minister's Office (CMO) stated on Saturday.

A tweet by CMO read, “CM Uddhav Balasaheb Thackeray has been assured of maximum support by Mr Adar Poonawalla and the Serum Institute of India to ensure maximum vaccination at the earliest in the State of Maharashtra.”

Another tweet read, “We are proud to have a world-class institution like Serum Institute of India in our state and we look forward to a strategic partnership for the safety of our citizens from Covid-19.”

Meanwhile, Maharashtra on Saturday reported 67,160 fresh COVID-19 cases, a slight increase more than the day before when it reported 66,836 cases. The state also registered 676 deaths amid the infection. The caseload gone to 42,28,836 while the death tally reached 63,928. The case-fatality ratio in the state is at 1.51 per cent

On the positive side, the state also reported 63,818 recoveries taking the total number of recoveries to 34,68,610. With 2,86,412 new tests, the number of samples examined for coronavirus so far in Maharashtra went up to 2,54,60,008, according to the health department.

Maharashtra's COVID-19 recovery rate stood at 82.02 per cent while the fatality rate is 1.51 per cent. The state's positivity rate is 16.61 per cent.

Enjoyed reading The Bridge Chronicle?
Your support motivates us to do better. Follow us on Facebook, Instagram and Twitter to stay updated with the latest stories.
You can also read on the go with our Android and iOS mobile app.

Related Stories

No stories found.
logo
The Bridge Chronicle
www.thebridgechronicle.com